Navigation Links
Bayer Initiates Phase III Trial of Investigational Inhaled Amikacin Solution (BAY41-6551T) in Mechanically Ventilated Patients with Gram-negative Pneumonia
Date:4/16/2013

WAYNE, N.J., April 16, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. announced today that patient enrollment is underway in its global Phase III trial program to evaluate the efficacy and safety of adjunctive aerosolized BAY41-6551 versus aerosolized placebo in the treatment of intubated and mechanically ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.  BAY41-6551 consists of amikacin inhalation solution delivered by a Pulmonary Drug Delivery System (PDDS) developed by Nektar Therapeutics (NASDAQ: NKTR).

"Bayer continues to invest in research for potential treatment options for many difficult to treat diseases," said Pamela A. Cyrus , MD, Vice President and Head of U.S. Medical Affairs, Bayer HealthCare Pharmaceuticals.  "This study is designed to evaluate the effectiveness of a solution of amikacin formulated for inhalation, delivered through a proprietary drug delivery system, as an adjunctive therapy for Gram-negative pneumonia in intubated and mechanically ventilated patients."

About the Phase III INHALE Study Program
The global INHALE study program is comprised of two prospective, randomized, double-blind, placebo-controlled, multicenter studies to evaluate the safety and efficacy of BAY41-6551 as adjunctive therapy in intubated and mechanically-ventilated patients with Gram-negative pneumonia receiving standard of care intravenous antibiotics.  The study will enroll patients age 18 or above that have microbiologically-confirmed pneumonia caused by Gram-negative organisms.  INHALE will be a large multi-center global program involving centers in North America, South America, Europe, Japan, Australia and Asia.  For more information about th
'/>"/>

SOURCE Bayer HealthCare Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
2. Regeneron and Bayer Announce Co-Promotion Agreement With Santen For EYLEA® (aflibercept) Injection in Japan
3. Bayer Partnership Delivers Industry-First Dose Management Offering
4. Zacks Bull and Bear of the Day Highlights: Discover Financial Services, POSCO, AstraZeneca, Bayer and Takeda Pharmaceutical
5. U.S. FDA Grants Priority Review to the New Drug Application for Bayers Regorafenib to Treat Patients with Metastatic Colorectal Cancer
6. Bayer Submits New Drug Application for Regorafenib for the Treatment of Gastrointestinal Stromal Tumors (GIST)
7. Hagens Berman Sobol Shapiro LLP and Douglas & London P.C. Announce Proposed Class Action Settlement in Bayer Combination Aspirin Products Litigation
8. MediSapiens sapprête à fournir à Bayer HealthCare Pharmaceuticals une nouvelle application informatique en nuage pour analyser et visualiser les données génomiques multidimensionnelles
9. MediSapiens liefert neue Cloud-Computing-App zur Analyse und Visualisierung multidimensionaler Genomdaten an Bayer HealthCare Pharmaceuticals
10. MediSapiens to Provide Bayer HealthCare Pharmaceuticals With a New Cloud Computing Application to Analyze and Visualize Multi-Dimensional Genomics Data
11. Bayers Second Annual Virtual Walk for Hemophilia Raises Funds, Generates Excitement in the Hemophilia Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  A mere one in seven new ... Hamilton . A new white paper from ... impeding and disrupting manufacturers, success. The white ... Value In Product Development Processes provides insight into: ... how it affects the product development process resulting in: ...
(Date:8/27/2015)... Aug. 27, 2015 NorthStar Anesthesia , one ... it has been selected by Mercy, based in ... four of their hospitals:  Mercy St. Vincent  Medical Center and ... , Mercy St. Charles  Hospital in Oregon ... Tiffin . "As we looked to ...
(Date:8/27/2015)... , August 27, 2015 According ... Market by Type (Integrated, Standalone), by Deployment Mode (Web ... Physicians, Emergency Healthcare Service Providers), by Component - Global ... Systems Market is estimated at $501.1 Million 2014, and ... a CAGR of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Four Mercy Hospitals in Northwest Ohio Select NorthStar Anesthesia 2Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4
(Date:8/28/2015)... Raleigh, NC (PRWEB) , ... August 28, 2015 , ... ... mesothelioma will not be available for general use any time soon, according to educational ... MTG-201, a biologic therapy that received orphan drug designation for mesothelioma last week from ...
(Date:8/28/2015)... , ... August 28, 2015 , ... External Counterpulsation, also ... Fit Clinic is now selling External Counterpulsation (EECP or ECP) machines with a full ... Clinic has been in business since 2007 helping people prevent and reverse heart ...
(Date:8/28/2015)... ... August 28, 2015 , ... Inc. magazine today ranked ... exclusive ranking of the nation’s fastest-growing private companies. The list was unveiled online at ... of 85% over the last three years, PREVENT ranks higher on the list than ...
(Date:8/28/2015)... , ... August 28, 2015 , ... Santa Rosa was ... Work in Healthcare by Modern Healthcare. In the KLAS “2015 Midterm Performance Review: Software ... , “We believe the recognitions from Modern Healthcare and KLAS are directly related to ...
(Date:8/27/2015)... ... August 28, 2015 , ... Best-selling ... of foster care through “The Language of Flowers,” has joined the Youth Villages ... particularly the organization’s YVLifeSet program, was piqued by her passion for helping foster ...
Breaking Medicine News(10 mins):Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2Health News:Buy New External Counterpulsation (EECP or ECP) With Heart Fit Clinic 2Health News:PREVENT Life Safety Ranks No. 3660 on the 2015 Inc. 5000 With Three-Year Sales Growth of 85% 2Health News:Santa Rosa Consulting Recognized by Modern Healthcare as One of the Top 100 Best Places to Work and from KLAS Research with the Highest Rating for Go-Live Support 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 2Health News:Best-selling Author Vanessa Diffenbaugh Joins Youth Villages National Board of Directors 3
... a leading,international manufacturer, marketer, and supplier of protective ... 2007 fourth,quarter and full year financial results., ... generated net sales of,$253.7 million, an increase of ... fourth quarter of 2006. Excluding the impact of ...
... therapy has an impact on overall day-to-day living, experts ... issues should be weighed carefully when prostate cancer patients ... them, new research suggests. , Different therapies can ... living, and these outcomes need to be discussed with ...
... WASHINGTON, March 19 Health and Human,Services Secretary ... by Deirdre McQuade, spokesperson on pro-life issues for,the ... comments on March 19,following a public attack on ... The attack was prompted by a March ...
... and other chemicals in childhood may hike adult cancer risks, ... In the decades following World War II, both breast cancer ... United States -- and a new report contends there,s a ... Breast Cancer Fund, a non-profit group whose mission is to ...
... International Associates Inc.,administrator for the HealthShares(TM) Indexes, a series ... announced the,quarterly rebalancing of the Indexes., The following ... before the opening of trading on NYSE Arca March ... GW Pharmaceuticals, Inc (LSE: GWP.L) ...
... March 19 Integrated,Pharmaceutical, Inc. (OTC Bulletin ... orders for its new no calorie, electrolyte ... and Magnesium, called,HEALTHYCAL+. The first bottles are ... Sales representatives report more than 40 ...
Cached Medicine News:Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 2Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 3Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 4Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 5Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 6Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 7Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 8Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 9Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 10Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 11Health News:Quality of Life an Issue in Prostate Cancer Treatment 2Health News:Quality of Life an Issue in Prostate Cancer Treatment 3Health News:HHS Secretary Leavitt Praised for Defending Physicians' Conscience Rights 2Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 2Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 3Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 4Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Health News:Retailers Sign on to Sell the New HEALTHYCAL+ Water Beverage - Even Before First Bottle is Packaged 2Health News:Retailers Sign on to Sell the New HEALTHYCAL+ Water Beverage - Even Before First Bottle is Packaged 3
A budget-priced microscope designed for ENT and neuro surgery....
The OPMI Neuro/NC4 System is the system of choice for integration with every major Image Guided Surgery (IGS). It can be mounted on NC4 floorstand or ceiling mount....
... microscope system has been designed ... fatigue. The maneuverability of this ... provides fatigue-free viewing even at ... as in posterior fossa, cerebral ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
Medicine Products: